Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus

StatusActive
Effective start/end date17/10/19 → 16/10/20

Funding

  • Janssen Pharmaceuticals: $183,562.00
View all
View less

Keywords

  • Infectious Diseases